![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF
has similar efficacy and is well-tolerated compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve females at Week 96
|
|
|
Reported by Jules Levin
Infectious Disease Week
October 8-12, 2014
Philadelphia, PA
Creticos, C1, Brinson, C2, McDonald, C3, Segal-Maurer, S4, Brar, I5, Wade, B6, garner, W7, Porter, D7, De-oertel, S7, Weinberg, A7, sparrow, t7
1Howard Brown Health Center, Chicago, IL; 2Red River Family Practice, Austin, TX, USA; 3Tarrant County Infectious Disease, Fort Worth, TX, USA; 4New York Hospital Queens, Flushing, NY, USA; 5Henry Ford Hospital, Detroit, MI, USA; 6Center for Prevention/Treatment, Pensacola, FL, USA; 7Gilead Sciences, Foster City, CA, USA
![IDSA1.gif](../images/101014/101014-4/IDSA1.gif)
![IDSA2.gif](../images/101014/101014-4/IDSA2.gif)
![IDSA3.gif](../images/101014/101014-4/IDSA3.gif)
![IDSA4.gif](../images/101014/101014-4/IDSA4.gif)
![IDSA5.gif](../images/101014/101014-4/IDSA5.gif)
![IDSA6.gif](../images/101014/101014-4/IDSA6.gif)
![IDSA7.gif](../images/101014/101014-4/IDSA7.gif)
![IDSA8.gif](../images/101014/101014-4/IDSA8.gif)
![IDSA9.gif](../images/101014/101014-4/IDSA9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|